Regen Biopharma Stock Today
| RGBPP Stock | USD 0.06 0.0001 0.17% |
PerformanceModest
| Odds Of DistressBelow Average
|
Regen BioPharma is selling at 0.06 as of the 19th of March 2025; that is 0.17 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.06. Regen BioPharma has about a 26 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California. Regen Biopharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.. The company has 158.73 M outstanding shares. More on Regen BioPharma
Moving against Regen Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Regen Pink Sheet Highlights
| Chairman | David Koos |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Regen BioPharma [RGBPP] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 335.96 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Regen BioPharma's market, we take the total number of its shares issued and multiply it by Regen BioPharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Regen BioPharma classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 158.73 M outstanding shares.
Regen BioPharma has accumulated about 110.99 K in cash with (606.92 K) of positive cash flow from operations.
Check Regen BioPharma Probability Of Bankruptcy
Ownership AllocationRegen BioPharma owns a total of 158.73 Million outstanding shares. Regen BioPharma has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Regen Ownership Details
Regen BioPharma Risk Profiles
| Mean Deviation | 12.74 | |||
| Semi Deviation | 12.94 | |||
| Standard Deviation | 17.42 | |||
| Variance | 303.44 |
Regen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Regen BioPharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Additional Tools for Regen Pink Sheet Analysis
When running Regen BioPharma's price analysis, check to measure Regen BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regen BioPharma is operating at the current time. Most of Regen BioPharma's value examination focuses on studying past and present price action to predict the probability of Regen BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regen BioPharma's price. Additionally, you may evaluate how the addition of Regen BioPharma to your portfolios can decrease your overall portfolio volatility.